Breast Cancer Research Funding Opportunities from Susan G. Komen for the Cure
The Susan G. Komen for the Cure has announced the following funding opportunities.
Investigator-Initiated and Career Catalyst Research Grants
Pre-Applications Due - June 25, 2010, 8 p.m., EDT
Full-Applications Due (invitation only) - November 11, 2010, 8 p.m., EDT
Investigator-Initiated Research (IIR) - Please note that the research focus for IIR Grants have changed significantly; review the Request for Applications (RFA) carefully!
This year's research areas are as follows: Molecular Predictors of High Risk and Early Disease; Targeted Therapies for Endocrine Resistant Disease; Therapeutic Implications of Micrometastases; Epigenetic Alterations; and all issues relevant to Disparities in Breast Cancer Outcomes across Population Groups.
IIR Grants provide up to $600,000 over three years to stimulate exploration of new ideas and novel approaches in breast cancer research and clinical practice that will lead to reductions in breast cancer incidence and mortality within the next decade. Komen is introducing a new approach to its IIR RFA in an effort to align supported research projects with Komen's annual strategic objectives and to provide consistency for the research community.
Please carefully review the research focus areas as described in the RFA; applications addressing topics other than those listed will be administratively withdrawn from consideration.
Career Catalyst Research (CCR) Grants -
CCR Grants provide unique opportunities for scientists in the early stages of their career to achieve research independence with an independent award of up to $450,000 over three years. CCR investigators lead a research project addressing an important question in breast cancer research and complete a self-defined career development plan with support from a mentor committee. This year's annual research focus areas are: Biology and Translation, and Disparities in Breast Cancer Outcomes.
Pre-Applications Due - July 25, 2010, 8 p.m., EDT
Full-Applications Due (invitation only) - December 1, 2010, 8 p.m., EDT
Promise Grants - Promise Grants provide up to $6.5 million over five years to support programs with collaborative and cross-disciplinary research projects that provide integrated approaches to solving critical challenges to the rapid translation of scientific discoveries into new or enhanced clinical tools and applications that have the greatest potential to significantly reduce breast cancer incidence and/or mortality within the next decade. Integrated programs of research projects addressing critical challenges in population disparities in breast cancer outcomes and triple negative breast cancer are of special interest and may receive funding priority. Pre-applications are required prior to starting a full application.
Details about Komen's Research Programs and other funding opportunities are available at: http://www.komen.org.